Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pui Yeng Lam

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Immunology and Cell Biology|September 13, 2024
A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapyGustavo R Rossi, Jane Sun, Cheng-Yu Lin, et al.
Nature Communications|November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammationTimothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Blood|August 21, 2020
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environmentTakumi Kobayashi, Pui Yeng Lam, Hui Jiang, et al.
Frontiers in Medicine|July 25, 2022
Spatially Resolved Transcriptomes of Mammalian Kidneys Illustrate the Molecular Complexity and Interactions of Functional Nephron SegmentsArti M Raghubar, Duy T Pham, Xiao Tan, et al.
The Journal of Clinical Investigation|August 16, 2016
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammationAdrian Achuthan, Andrew D Cook, Ming-Chin Lee, et al.
Clinical and Translational Medicine|January 7, 2025
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CARPui Yeng Lam, Natacha Omer, Josh K M Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapyJoshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Immunology and Cell Biology|September 13, 2024
A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapyGustavo R Rossi, Jane Sun, Cheng-Yu Lin, et al.
Nature Communications|November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammationTimothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Blood|August 21, 2020
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environmentTakumi Kobayashi, Pui Yeng Lam, Hui Jiang, et al.
Frontiers in Medicine|July 25, 2022
Spatially Resolved Transcriptomes of Mammalian Kidneys Illustrate the Molecular Complexity and Interactions of Functional Nephron SegmentsArti M Raghubar, Duy T Pham, Xiao Tan, et al.
The Journal of Clinical Investigation|August 16, 2016
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammationAdrian Achuthan, Andrew D Cook, Ming-Chin Lee, et al.
Clinical and Translational Medicine|January 7, 2025
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CARPui Yeng Lam, Natacha Omer, Josh K M Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapyJoshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Pageof 2